Evidence map›Paper›PMID 38830163›Full record

ArticleHealth affairs (Project Hope)2024

Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore's Experience.

Omeid Heidari, Diane Meyer, Kelly Lowensen, Amita Patil, Katie J O'Conor, Jessica LaRicci, Derrick Hunt, Adam P Bocek, Victoria Cargill, Jason E Farley

Abstract read
In one paragraph

Article in Health affairs (Project Hope), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Omeid HeidariOmeid Heidari (oheidar1@uw.edu), University of Washington, Seattle, Washington.
Diane MeyerDiane Meyer, Johns Hopkins University, Baltimore, Maryland.
Kelly LowensenKelly Lowensen, Johns Hopkins University.
Amita PatilAmita Patil, Johns Hopkins University.
Katie J O'ConorKatie J. O'Conor, Johns Hopkins University.
Jessica LaRicciJessica LaRicci, Johns Hopkins University.
Derrick HuntDerrick Hunt, Baltimore City Health Department, Baltimore, Maryland.
Adam P BocekAdam P. Bocek, Johns Hopkins University.
Victoria CargillVictoria Cargill, Milken Institute, Washington, D.C.
Jason E FarleyJason E. Farley, Johns Hopkins University.

Funding

NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
NCATS NIH HHS KL2 TR002317
6 · The paper itself

Abstract

People who inject drugs face many challenges that contribute to poor health outcomes, including drug overdose, HIV, and hepatitis C infections. These conditions require high-quality prevention and treatment services. Syringe services programs are evidence-based harm reduction programs, and they have established track records with people who inject drugs, earning them deep trust within this population. In Baltimore, Maryland, although many syringe support services were limited during the COVID-19 pandemic, the health department's syringe services programs remained operational, allowing for the continuation of harm reduction services, including naloxone distribution. This evaluation describes a collaborative effort to colocate infectious disease testing and COVID-19 vaccination with a syringe services program. Our evaluation demonstrated that colocation of important services with trusted community partners can facilitate engagement and is essential for service uptake. Maintaining adequate and consistent funding for these services is central to program success. Colocation of other services within syringe services programs, such as medications for opioid use disorder, wound care, and infectious disease treatment, would further expand health care access for people who inject drugs.

Indexed as

COVID-19COVID-19 VaccinesNeedle-Exchange ProgramsSubstance Abuse, IntravenousBaltimoreCOVID-19 TestingHarm ReductionHealth Services AccessibilityHIV InfectionsHumansCOVID-19 Vaccines

Identifiers

PMID38830163
PMCPMC11567152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.